DICE Therapeutics Inc (DICE)

US23345J1043 - Common Stock

47.55  +0.03 (+0.06%)

After market: 47.59 +0.04 (+0.08%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-3-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.001.13M863.00K5.78M
Operating Expenses
100.94M88.22M48.73M24.58M18.52M
Research and Development
72.81M62.56M36.51M19.58M14.91M
Selling, General, and Administrative Expenses
28.13M25.66M12.22M5.00M3.61M
Operating Income
-100.94M-88.22M-47.60M-23.72M-12.75M
Interest Income/Expense
10.20M4.53M-38.00K126.00K609.00K
Other Income/Expense
N/A0.00-1.32M-144.00K0.00
Non Recurring Items
N/A-200.00KN/A0.00-800.00K
Income Before Taxes
-90.94M-83.89M-48.96M-23.74M-12.94M
Net Income
-90.94M-83.89M-48.96M-23.74M-12.94M
EBITDA
-100.02M-87.40M-46.94M-23.02M-12.04M
 
Per Share Data
EPS Diluted Total Ops
-2.18-2.13-1.28-0.65-0.36
Non GAAP EPS
-2.18-2.14N/AN/AN/A
 
Statistics
Profit Margin
N/AN/A-4351.91%-2750.75%-224.03%
Operating Profit Margin
N/AN/A-4231.38%-2748.67%-220.73%

All data in USD

Charts